N-[2-(1H-benzimidazol-2-yl)ethyl]-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide
Chemical Structure Depiction of
N-[2-(1H-benzimidazol-2-yl)ethyl]-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide
N-[2-(1H-benzimidazol-2-yl)ethyl]-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide
Compound characteristics
| Compound ID: | J100-0331 |
| Compound Name: | N-[2-(1H-benzimidazol-2-yl)ethyl]-2-[(3R)-2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl]acetamide |
| Molecular Weight: | 377.4 |
| Molecular Formula: | C20 H19 N5 O3 |
| Smiles: | C(CNC(C[C@@H]1C(Nc2ccccc2C(N1)=O)=O)=O)c1nc2ccccc2[nH]1 |
| Stereo: | ABSOLUTE |
| logP: | 1.1105 |
| logD: | 1.0846 |
| logSw: | -2.2708 |
| Hydrogen bond acceptors count: | 7 |
| Hydrogen bond donors count: | 4 |
| Polar surface area: | 95.545 |
| InChI Key: | SDISCUDVKSQVSK-MRXNPFEDSA-N |